Serum Institute's Covishield likely to get a nod from drug regulatory

Serum Institute of India's Covishield vaccine which is made in collaboration with Oxford is likely to get a nod in India by the expert panel committee appointed by the government to review to emergency use vaccine in India. This comes just before all the states are scheduled to take a dry run for the Covid vaccine from tomorrow. Three companies are going to give a presentation for their vaccines in front of the drug regulations. Bharat Biotech and Pfizer along with Serum Institute of India are also in the line. According to sources Oxford's vaccine is most likely to receive a clean chit for emergency use in India. The news is expected to be out anytime soon!